These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3295239)

  • 1. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
    Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
    J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
    Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
    J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of (2R, 3R, 4R, 5S)-5-tert-Butyloxycarbonylamino-3,4-Dihydroxy-2-1sopropyl-3,4-O,O-Isopropylidene-6-CyctohexyI-Hexanoic Acid.
    Scott A; Conway BG; Krook MA
    Methods Mol Med; 1999; 23():437-52. PubMed ID: 21380912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin inhibitory peptides.
    Thaisrivongs S; Schostarez HJ; Pals DT; Turner SR
    J Med Chem; 1987 Oct; 30(10):1837-42. PubMed ID: 3309315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
    Johnson RL; Verschoor K
    J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New renin inhibitors containing novel analogues of statine.
    Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
    J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue.
    Atsuumi S; Nakano M; Koike Y; Tanaka S; Funabashi H; Matsuyama K; Nakano M; Sawasaki Y; Funabashi K; Morishima H
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3214-21. PubMed ID: 1294323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues.
    Thaisrivongs S; Pals DT; Kati WM; Turner SR; Thomasco LM; Watt W
    J Med Chem; 1986 Oct; 29(10):2080-7. PubMed ID: 3531517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.
    Atsuumi S; Nakano M; Koike Y; Tanaka S; Matsuyama K; Nakano M; Morishima H
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):364-70. PubMed ID: 1606632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitors. III. Synthesis and structure-activity relationships of transition-state inhibitors containing dihydroxyethylene isostere at the P1-P1 site.
    Atsuumi S; Funabashi H; Nakano M; Koike Y; Tanaka S; Harada J; Matsuyama K; Ikenaga T; Morishima H
    Chem Pharm Bull (Tokyo); 1994 Feb; 42(2):306-13. PubMed ID: 8149456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activities of renin inhibitors containing statine analogues.
    Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
    Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
    J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
    Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
    J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.